ENTELLUS MED INC - COM (ENTL)

CUSIP: 29363K105

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
20,401,652
Share change
+2,197,585
Total reported value
$376,603,131
Price per share
$18.46
Number of holders
72
Value change
+$42,182,831
Number of buys
35
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 29363K105?
CUSIP 29363K105 identifies ENTL - ENTELLUS MED INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ENTELLUS MED INC - COM (ENTL) as of Q3 2017

As of 30 Sep 2017, ENTELLUS MED INC - COM (ENTL) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,401,652 shares. The largest 10 holders included Essex Woodlands Health Ventures, Inc., SV Health Investors, LLC, Discovery Group I, LLC, Kohlberg Kravis Roberts & Co. L.P., FRONTIER CAPITAL MANAGEMENT CO LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MILLENNIUM MANAGEMENT LLC, ArrowMark Colorado Holdings LLC, First Light Asset Management, LLC, and BlackRock Inc.. This page lists 72 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.